The Role Of JPM In Helping Place Two Biopharma Startup CEOs
Source: Life Science Leader
Most know the importance of the annual J.P. Morgan Healthcare Conference (JPM) to the biopharmaceutical industry. In this executive virtual roundtable (EVR) section (view full video here), Faraz Ali, CEO of Tenaya Therapeutics, and Rahul Ballal, Ph.D., CEO of Imara, share how JPM in 2018 helped connect each to their respective biopharmaceutical startup opportunities.
This website uses cookies to ensure you get the best experience on our website. Learn more